/002581.SZ

002581.SZ Stock - Shandong Sinobioway Biomedicine Co., Ltd.

Q: What is the analyst price target for 002581.SZ?

Analyst price target information is not currently available for 002581.SZ.

Q: What is 002581.SZ's market cap?

Market capitalization information is not currently available for 002581.SZ.

Basic Materials|Chemicals - Specialty|SHZ

$7.73-1.15%

$0.09 (-1.15%) • Dec 25

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $8.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for 002581.SZ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.37

52W High$11.74

52W Low$5.69

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$360.41M	$429.79M	$357.08M	$402.71M	$276.83M
Gross Profit	$287.55M	$336.50M	$280.87M	$316.88M	$222.50M
Gross Margin	79.8%	78.3%	78.7%	78.7%	80.4%
Operating Income	$-111,471,974	$-293,351,196	$33.67M	$273.08M	$-195,659,765.8
Net Income	$-137,313,572	$-332,458,291	$-14,680,302	$271.00M	$-195,934,410
Net Margin	-38.1%	-77.4%	-4.1%	67.3%	-70.8%
EPS	$-0.60	$-0.50	$-0.02	$0.41	$-0.30

Company Overview

Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a murine nerve growth factor for injection; Anferon, a human recombinant interferon alpha 2b injection; and Jaferon, a human recombinant interferon alpha 2b spray. In addition, it offers Healive, an inactivated hepatitis A vaccine; Bilive, a combined hepatitis A and B Vaccine; Panflu, a pandemic influenza vaccine; Anflu, a preservative-free influenza virus vaccine; Panflu.1, a Type A H1N1 influenza vaccine; etc. Further, the company exports its products to approximately 20 counties and regions in Europe and the United States. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is headquartered in Zibo, China.

Visit Website

Earnings History & Surprises

002581.SZ

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.13

Q2 2025

EPS Surprise History

Q4 23

No data

Q1 24

No data

Q2 24

No data

Q2 24

No data

Q3 24

No data

Q1 25

No data

Q2 25

No data

Q2 25

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2025	Jun 30, 2025	—	$-0.13	—	—
Q2 2025	May 22, 2025	—	$-0.66	—	—
Q1 2025	Mar 31, 2025	—	$-0.06	—	—
Q3 2024	Sep 30, 2024	—	$0.19	—	—
Q2 2024	Jun 30, 2024	—	$-0.00	—	—
Q2 2024	May 22, 2024	—	$-0.04	—	—
Q1 2024	Jan 16, 2024	—	$0.13	—	—
Q4 2023	Dec 31, 2023	—	$-0.55	—	—
Q2 2023	Jun 30, 2023	—	$-0.05	—	—
Q1 2023	Mar 31, 2023	—	$-0.03	—	—
Q1 2023	Jan 1, 2023	—	$-0.12	—	—
Q3 2022	Sep 30, 2022	—	$0.06	—	—
Q2 2022	Jun 30, 2022	—	$0.03	—	—
Q1 2022	Mar 31, 2022	—	$0.01	—	—
Q4 2021	Dec 31, 2021	—	$-0.12	—	—
Q3 2021	Sep 30, 2021	—	$0.32	—	—
Q2 2021	Jun 30, 2021	—	$0.17	—	—
Q2 2021	Apr 29, 2021	—	$-0.14	—	—
Q1 2021	Mar 31, 2021	—	$0.04	—	—
Q3 2020	Sep 30, 2020	—	$-0.02	—	—

Frequently Asked Questions about 002581.SZ

What is 002581.SZ's current stock price?

Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ) is currently trading at $7.73 per share. The stock has moved -1.15% today.

What is the analyst price target for 002581.SZ?

No analyst price targets are currently available for this stock.

What sector is Shandong Sinobioway Biomedicine Co., Ltd. in?

Shandong Sinobioway Biomedicine Co., Ltd. operates in the Basic Materials sector, specifically within the Chemicals - Specialty industry. The company is traded on the SHZ exchange.

What is 002581.SZ's market cap?

Shandong Sinobioway Biomedicine Co., Ltd. has a market capitalization of $5.10 billion, making it a mid-cap company.

Does 002581.SZ pay dividends?

No, Shandong Sinobioway Biomedicine Co., Ltd. does not currently pay a dividend to shareholders.